MicroPort NeuroTech Secures FDA Approval for NUMEN Helia Spring Coil System – Advanced Solution for Complex Neurovascular Lesions
MicroPort NeuroTech Limited (HKG: 2172) announced it has received marketing approval from the U.S. Food...
MicroPort NeuroTech
MicroPort NeuroTech’s NUMEN Nest Gains FDA Marketing Approval
China-based MicroPort NeuroTech Limited (HKG: 2172) announced that its NUMEN Nest, an enhanced version of...
MicroPort NeuroTech Leads Investment Fund to Advance Brain Science Industry
China-based MicroPort NeuroTech Limited (HKG: 2172) has announced its commitment to invest RMB 200 million...
MicroPort NeuroTech’s NUMEN Silk Receives FDA Approval for Embolization Treatment
MicroPort NeuroTech Limited (HKG: 2172), a Chinese medical device company, has announced that it has...
MicroPort Scientific Plans IPO for Subsidiary MicroPort CRM on Hong Kong Stock Exchange
Shanghai-based medical device giant MicroPort Scientific Corp. (HKG: 0853) has announced its intention to spin...
MicroPort NeuroTech Lists in Hong Kong with $43.3 Million IPO
MicroPort NeuroTech Limited has successfully completed its initial public offering (IPO) on the Hong Kong...